199658-92-9Relevant articles and documents
5-Thienyltryptamine derivatives as serotonin 5-HT(1B/1D) receptor agonists: Potential treatments for migraine
Meng, Charles Q.,Rakhit, Suman,Lee, David K. H.,Kamboj, Rajender,McCallum, Kirk L.,Mazzocco, Lucy,Dyne, Kerry,Slassi, Abdelmalik
, p. 903 - 905 (2000)
A series of 5-(2- or 3-thienyl)tryptamine derivatives (9) has been synthesized and shown to be potent and selective 5-HT(1D) versus 5-HT(1B) receptor agonists and, therefore, potential treatments for migraine. (C) 2000 Elsevier Science Ltd. All rights reserved.
3-(2-Pyrrolidin-1-ylethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)-1H-indole derivatives as high affinity human 5-HT1B/1D ligands
Egle, Ian,MacLean, Neil,Demchyshyn, Lidia,Edwards, Louise,Slassi, Abdelmalik,Tehim, Ashok
, p. 727 - 729 (2007/10/03)
A series of 3-(2-pyrrolidin-1-ylethyl)-5-(1,2,3,6-tetrahydropyridin-4-yl)- 1H-indole derivatives (2) has been prepared using parallel synthesis techniques, and their structure-activity relationships studied. High affinity human 5-HT1B/1D (h5-HT1B/1D) ligands have been identified.